Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
regulatory procedure
|
| gptkbp:administeredBy |
gptkb:World_Health_Organization
|
| gptkbp:appliesTo |
vaccines
therapeutics diagnostics |
| gptkbp:criteria |
safety
quality efficacy risk management plan |
| gptkbp:enables |
gptkb:emergency_use_authorization
expedited assessment |
| https://www.w3.org/2000/01/rdf-schema#label |
EUL (Emergency Use Listing)
|
| gptkbp:introducedIn |
2014
|
| gptkbp:notableFor |
gptkb:COVID-19_vaccines
|
| gptkbp:purpose |
facilitate availability of medical products during public health emergencies
|
| gptkbp:relatedTo |
gptkb:WHO_Prequalification
|
| gptkbp:bfsParent |
gptkb:Nuvaxovid
gptkb:Vaxzevria |
| gptkbp:bfsLayer |
6
|